These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 24245692)
21. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction. Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453 [TBL] [Abstract][Full Text] [Related]
22. Se-methylselenocysteine inhibits the progression of non-small cell lung cancer via ROS-mediated NF-κB signaling pathway. Ge L; Liu P; Tian L; Li Y; Chen L Exp Cell Res; 2024 Jul; 440(1):114101. PubMed ID: 38815788 [TBL] [Abstract][Full Text] [Related]
23. Gambogic acid sensitizes resistant breast cancer cells to doxorubicin through inhibiting P-glycoprotein and suppressing survivin expression. Wang S; Wang L; Chen M; Wang Y Chem Biol Interact; 2015 Jun; 235():76-84. PubMed ID: 25824409 [TBL] [Abstract][Full Text] [Related]
24. Targeting renal cell carcinoma with gambogic acid in combination with sunitinib in vitro and in vivo. Jiang XL; Zhang Y; Luo CL; Wu XH Asian Pac J Cancer Prev; 2012; 13(12):6463-8. PubMed ID: 23464475 [TBL] [Abstract][Full Text] [Related]
25. Involvement of RECK in gambogic acid induced anti-invasive effect in A549 human lung carcinoma cells. Qi Q; Lu N; Li C; Zhao J; Liu W; You Q; Guo Q Mol Carcinog; 2015 Jun; 54 Suppl 1():E13-25. PubMed ID: 24532189 [TBL] [Abstract][Full Text] [Related]
26. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678 [TBL] [Abstract][Full Text] [Related]
27. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
28. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer. Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500 [TBL] [Abstract][Full Text] [Related]
29. Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro. Hu Y; Zang J; Cao H; Wu Y; Yan D; Qin X; Zhou L; Fan F; Ni J; Xu X; Sha H; Liu S; Yu S; Wang Z; Ma R; Wu J; Feng J Oncotarget; 2017 Feb; 8(9):15802-15814. PubMed ID: 28178657 [TBL] [Abstract][Full Text] [Related]
30. 4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway. Wang XN; Wang KY; Zhang XS; Yang C; Li XY Biochem Biophys Res Commun; 2018 Oct; 504(4):812-819. PubMed ID: 30217455 [TBL] [Abstract][Full Text] [Related]
31. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells. Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986 [TBL] [Abstract][Full Text] [Related]
32. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation. Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430 [TBL] [Abstract][Full Text] [Related]
33. Phytochemical naphtho[1,2-b] furan-4,5‑dione induced topoisomerase II-mediated DNA damage response in human non-small-cell lung cancer. Chien CM; Yang JC; Wu PH; Wu CY; Chen GY; Wu YC; Chou CK; Tseng CH; Chen YL; Wang LF; Chiu CC Phytomedicine; 2019 Feb; 54():109-119. PubMed ID: 30668360 [TBL] [Abstract][Full Text] [Related]
34. Gambogic acid promotes apoptosis and resistance to metastatic potential in MDA-MB-231 human breast carcinoma cells. Li C; Qi Q; Lu N; Dai Q; Li F; Wang X; You Q; Guo Q Biochem Cell Biol; 2012 Dec; 90(6):718-30. PubMed ID: 23194187 [TBL] [Abstract][Full Text] [Related]
35. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition. Zhao K; Zhang S; Song X; Yao Y; Zhou Y; You Q; Guo Q; Lu N Oncotarget; 2017 Apr; 8(16):27120-27136. PubMed ID: 28404892 [TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way. Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471 [TBL] [Abstract][Full Text] [Related]
37. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner. Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089 [TBL] [Abstract][Full Text] [Related]
38. Key role of nuclear factor-κB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2. Zhang J; Lu M; Zhou F; Sun H; Hao G; Wu X; Wang G Drug Metab Dispos; 2012 Oct; 40(10):1900-8. PubMed ID: 22745335 [TBL] [Abstract][Full Text] [Related]
39. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model. Tang FY; Chiang EP; Pai MH J Agric Food Chem; 2010 Oct; 58(20):11156-64. PubMed ID: 20866043 [TBL] [Abstract][Full Text] [Related]
40. Dendrobine targeting JNK stress signaling to sensitize chemotoxicity of cisplatin against non-small cell lung cancer cells in vitro and in vivo. Song TH; Chen XX; Lee CK; Sze SC; Feng YB; Yang ZJ; Chen HY; Li ST; Zhang LY; Wei G; Shi J; Xu K; Ng TB; Zhu LL; Zhang KY Phytomedicine; 2019 Feb; 53():18-27. PubMed ID: 30668397 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]